News

Healthcare stocks have struggled in 2026. With a year-to-date (YTD) loss of about 6%, that corner of the market has been the worst performer among all 11 sectors of the S&P 500 in 2026.

While that

• 3 Stocks With High ROE and Market-Beating Growth Potential

Docebo (NASDAQ:DCBO) used its Q1 2026 earnings call primarily to discuss demand trends and customer interest following its recent Inspire

• Trending Stocks: How to Spot, Trade, and Profit Safely

AMC Networks (NASDAQ:AMCX) executives highlighted streaming revenue growth, improving advertising trends, and continued free cash flow

ALX Oncology (NASDAQ:ALXO) executives used the company’s first-quarter 2026 earnings call to highlight new clinical data for its lead CD47 blocker, evorpacept, and to provide updates on its

NetScout Systems (NASDAQ:NTCT) reported fourth quarter and full fiscal year 2026 results that executives said were driven by growth across its cybersecurity and service assurance offerings

Maravai LifeSciences (NASDAQ:MRVI) reported first-quarter fiscal 2026 results that management said marked a “strong start to 2026,” driven by growth at its TriLink segment, steady contribution from

• Progress Software: Making Progress Driven by the AI Revolution

Progress Software (NASDAQ:PRGS) held its 2026 annual meeting of stockholders in a virtual-only format, with President and CEO Yogesh

Malibu Boats (NASDAQ:MBUU) reported fiscal third-quarter 2026 results that management said exceeded guidance on its legacy business and included a partial-month contribution from newly acquired

Lexicon Pharmaceuticals (NASDAQ:LXRX) executives highlighted progress across late-stage regulatory programs and efforts to bolster the company’s financial position during the company’s

Lesaka Technologies (NASDAQ:LSAK) reported third-quarter fiscal 2026 results that management described as strong on a largely like-for-like basis, with year-over-year gains in net revenue

• Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore

Lantheus (NASDAQ:LNTH) reported what management described as a strong start to 2026, citing solid performance from its three core

• Analysts Are Bullish on These 3 Laser Tech Companies

nLight (NASDAQ:LASR) reported what management called an “exceptional” first quarter of 2026, with revenue, margins, and profitability coming in

• These 3 Small-Cap Stocks Are Built to Weather a Slowdown

Kulicke and Soffa Industries (NASDAQ:KLIC) reported fiscal second-quarter 2026 results that management said reflected faster-than-expected

• 3 Stocks Trading Near $5 With Massive Earnings Upside

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported a strong start to 2026 and reiterated its full-year outlook, pointing to sharp first-quarter

A staggering 64% single-day stock appreciation on more than 30 times the average trading volume is rarely a quiet event. For storage cloud platform Backblaze, Inc. (NASDAQ: BLZE), the explosive

Eli Lilly and Company (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) are two weight-loss and diabetes drug stocks that have been on completely different trajectories. Since the start of 2025, LLY is